Pharmacists in Ruckersville, VA Accepting Medicare

7 Pharmacists found. Showing 1 - 7

Christy Huey Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 9026 Seminole Trl, Ruckersville, VA 22968 Phone: 434-985-3067

Dariska Walker, PHARM.D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 135 Stoneridge Dr N, Ruckersville, VA 22968 Phone: 434-990-6003    Fax: 434-990-6080

Dr. Nathan Edward Braginetz, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 135 Stoneridge Dr N, Ruckersville, VA 22968 Phone: 434-990-6003

Brandi Ruhlman-bidwell, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 135 Stoneridge Dr S, Ruckersville, VA 22968 Phone: 434-990-6003

Dmytro I Tyshchyshyn Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 9026 Seminole Trl, Ruckersville, VA 22968 Phone: 434-985-3067

Dr. Anne Stine, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 9026 Seminole Trl, Ruckersville, VA 22968 Phone: 434-985-3067

Andy Thien Nguyen Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 9026 Seminole Trl, Ruckersville, VA 22968 Phone: 434-985-3067

News Archive

New biomaterial allows scientists to study how stem cells sense stiffness of surrounding environment

A new biomaterial can be used to study how and when stem cells sense the mechanics of their surrounding environment, found a team led by Robert Mauck, PhD, the Mary Black Ralston Professor for Education and Research in Orthopaedic Surgery, in the Perelman School of Medicine at the University of Pennsylvania.

AccuDial Pharmaceutical introduces eight new OTC medications in Canada

AccuDial® Pharmaceutical, Inc. delivered a power-packed launch with their new family of eight over-the-counter (OTC) medications in Canada. Colorful floor displays enjoyed prominent placement in every Quebec Walmart pharmacy, and were filled with AccuDial's pain and fever, allergy, and cough and cold pediatric medications.

Pfizer Oncology to present early-stage research of investigational agents for cancer treatment

Pfizer Oncology will present data from across its portfolio, including results from long-term follow-up of Aromasin® (exemestane tablets) in a study of early breast cancer, updated study results from a Phase 3 study of Sutent® (sunitinib malate) in pancreatic neuroendocrine tumors (NET), and early-stage research of investigational agents PF-02341066 and figitumumab (CP-751,871) in patients with non-small cell lung cancer (NSCLC).

FDA approves Valeant's Potiga Tablets for treatment of partial-onset seizures

Valeant Pharmaceuticals International, Inc. and GlaxoSmithKline announced today that the U.S. Food and Drug Administration (FDA) has approved Potiga Tablets, a potassium channel opener, as adjunctive treatment of partial-onset seizures in patients aged 18 years and older.

maxIT Healthcare, Ingenuity Solutions Group enter definitive agreement to merge

maxIT Healthcare, LLC and Ingenuity Solutions Group, Inc. announced today that they have entered into a definitive agreement, under which the companies will be combined as maxIT Healthcare. The combined company is now better positioned to extend its presence throughout the healthcare IT professional services market, particularly in the area of Enterprise Resource Planning (ERP) system solutions.

Read more Medical News

› Verified 5 days ago